Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 16, 2016 - Issue 6
Submit an article Journal homepage
953
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Hepatitis C: how has France limited the expenses related to new treatments?

Anne-Laure MouterdeEvaluation and Proper Use of Health Products, General Agency of Equipment and Health Products, Assistance Publique-Hôpitaux de Paris (AP-HP) 7 rue du Fer à Moulin, 75005Paris, FranceCorrespondence[email protected]
View further author information
,
François BocquetEvaluation and Proper Use of Health Products, General Agency of Equipment and Health Products, Assistance Publique-Hôpitaux de Paris (AP-HP) 7 rue du Fer à Moulin, 75005Paris, France;Health Law and Health Economics Departement, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, 4 avenue de l'Obervatoire, 75006Paris, France;Health Law Institute, Inserm, UMR S 1145, Paris Descartes University, Sorbonne Paris Cité. 45 rue des Saints-Pères, 75006Paris, FranceView further author information
,
Isabelle FusierEvaluation and Proper Use of Health Products, General Agency of Equipment and Health Products, Assistance Publique-Hôpitaux de Paris (AP-HP) 7 rue du Fer à Moulin, 75005Paris, FranceView further author information
&
Pascal PaubelEvaluation and Proper Use of Health Products, General Agency of Equipment and Health Products, Assistance Publique-Hôpitaux de Paris (AP-HP) 7 rue du Fer à Moulin, 75005Paris, France;Health Law and Health Economics Departement, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, 4 avenue de l'Obervatoire, 75006Paris, France;Health Law Institute, Inserm, UMR S 1145, Paris Descartes University, Sorbonne Paris Cité. 45 rue des Saints-Pères, 75006Paris, FranceView further author information
Pages 655-657 | Received 16 Aug 2016, Published online: 27 Oct 2016

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yuanqiong Hu, Dimitri Eynikel, Pascale Boulet & Gaelle Krikorian. (2020) Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib. Journal of Pharmaceutical Policy and Practice 13:1.
Read now

Articles from other publishers (2)

Alison D. Marshall, Jean-Michel Pawlotsky, Jeffrey V. Lazarus, Alessio Aghemo, Gregory J. Dore & Jason Grebely. (2018) The removal of DAA restrictions in Europe – One step closer to eliminating HCV as a major public health threat. Journal of Hepatology 69:5, pages 1188-1196.
Crossref
Cécile Brouard, Marjorie Boussac-Zarebska, Christine Silvain, Julien Durand, Victor de Lédinghen, Josiane Pillonel & Elisabeth Delarocque-Astagneau. (2017) Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015. BMC Infectious Diseases 17:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.